Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels
Journal of Personalized Medicine · 20.11.2023 · 13 (11) · 1621
DOI: 10.3390/jpm13111621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 20.11.2023. Verfasst von Aigul R Rakhmatullina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was funded by the subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities, Kazan Federal University.
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) are pivotal players in tissue repair and hold great promise as cell therapeutic agents for regenerative medicine. Additionally, they play a significant role in the development of various human diseases. Studies on MSC biology have encountered a limiting property of these cells, which includes a low number of passages and a decrease in differentiation potential during in vitro culture. Although common methods of immortalization through gene manipulations of cells are well established, the resulting MSCs vary in differentiation potential compared to primary cells and eventually undergo senescence. This study aimed to immortalize primary adipose-derived MSCs by overexpressing human telomerase reverse transcriptase (hTERT) gene combined with a knockdown of TP53. The research demonstrated that immortalized MSCs maintained a stable level of differentiation into osteogenic and chondrogenic lineages during 30 passages, while also exhibiting an increase in cell proliferation rate and differentiation potential towards the adipogenic lineage. Long-term culture of immortalized cells did not alter cell morphology and self-renewal potential. Consequently, a genetically stable line of immortalized adipose-derived MSCs (iMSCs) was established.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
ORCID-Profile: Albert A Rizvanov
Förderung
- This work was funded by the subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities
- Kazan Federal University
Zitieren
APA
Rakhmatullina, A. R., Mingaleeva, R. N., Gafurbaeva, D. U., Glazunova, O. N., Sagdeeva, A. R., Bulatov, E. R., Rizvanov, A. A., & Miftakhova, R. R. (2023). Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels. Journal of Personalized Medicine, 13(11), 1621. https://doi.org/10.3390/jpm13111621
Vancouver
Rakhmatullina AR, Mingaleeva RN, Gafurbaeva DU, Glazunova ON, Sagdeeva AR, Bulatov ER, et al. Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels. Journal of Personalized Medicine. 2023;13(11):1621. doi:10.3390/jpm13111621
BibTeX
@article{Rakhmatullina2023,
author = {Rakhmatullina, Aigul R and Mingaleeva, Rimma N and Gafurbaeva, Dina U and Glazunova, Olesya N and Sagdeeva, Aisylu R and Bulatov, Emil R and Rizvanov, Albert A and Miftakhova, Regina R},
title = {Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {11},
pages = {1621},
doi = {10.3390/jpm13111621}
}
EUVIMED